Tag: U.S. Securities and Exchange Commission
Royalty Pharma IPO Poised to Raise $1.96 Billion or More
(Bloomberg) -- Royalty Pharma Plc, a buyer of biopharmaceutical royalties, and its shareholders upsized an initial public offering and sold the shares at the top...
